Department of Radiology, Xuanwu Hospital, Capital Medical University, 100053, Beijing, China.
Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
J Cardiovasc Magn Reson. 2021 Mar 15;23(1):25. doi: 10.1186/s12968-021-00730-7.
Contrast-enhanced (CE) steady-state free precession (SSFP) CMR at 1.5T has been shown to be a valuable alternative to T2-based methods for the detection and quantifications of area-at-risk (AAR) in acute myocardial infarction (AMI) patients. However, CE-SSFP's capacity for assessment of AAR at 3T has not been investigated. We examined the clinical utility of CE-SSFP and T2-STIR for the retrospective assessment of AAR at 3T with single-photon-emission-computed tomography (SPECT) validation.
A total of 60 AMI patients (ST-elevation AMI, n = 44; non-ST-elevation AMI, n = 16) were recruited into the CMR study between 3 and 7 days post revascularization. All patients underwent T2-STIR, CE-bSSFP and late-gadolinium-enhancement CMR. For validation, SPECT images were acquired in a subgroup of patients (n = 30).
In 53 of 60 patients (88 %), T2-STIR was of diagnostic quality compared with 54 of 60 (90 %) with CE-SSFP. In a head-to-head per-slice comparison (n = 365), there was no difference in AAR quantified using T2-STIR and CE-SSFP (R = 0.92, p < 0.001; bias:-0.4 ± 0.8 cm, p = 0.46). On a per-patient basis, there was good agreement between CE-SSFP (n = 29) and SPECT (R = 0.86, p < 0.001; bias: - 1.3 ± 7.8 %LV, p = 0.39) for AAR determination. T2-STIR also showed good agreement with SPECT for AAR measurement (R = 0.81, p < 0.001, bias: 0.5 ± 11.1 %LV, p = 0.81). There was also a strong agreement between CE-SSFP and T2-STIR with respect to the assessment of AAR on per-patient analysis (R = 0.84, p < 0.001, bias: - 2.1 ± 10.1 %LV, p = 0.31).
At 3T, both CE-SSFP and T2-STIR can retrospectively quantify the at-risk myocardium with high accuracy.
在 1.5T 下,对比增强(CE)稳态自由进动(SSFP)CMR 已被证明是一种有价值的替代方法,可以用于检测和量化急性心肌梗死(AMI)患者的危险区(AAR)。然而,CE-SSFP 在 3T 下评估 AAR 的能力尚未得到研究。我们使用单光子发射计算机断层扫描(SPECT)进行验证,研究了 CE-SSFP 和 T2-STIR 在 3T 下用于回顾性评估 AAR 的临床应用价值。
共有 60 名 AMI 患者(ST 段抬高型 AMI,n=44;非 ST 段抬高型 AMI,n=16)在血管重建后 3-7 天内被纳入 CMR 研究。所有患者均进行 T2-STIR、CE-bSSFP 和晚期钆增强 CMR。在亚组患者(n=30)中获取 SPECT 图像进行验证。
在 60 名患者中的 53 名(88%)中,T2-STIR 的质量可用于诊断,而在 60 名患者中的 54 名(90%)中,CE-SSFP 的质量可用于诊断。在头对头的每片比较(n=365)中,使用 T2-STIR 和 CE-SSFP 定量的 AAR 没有差异(R=0.92,p<0.001;偏差:-0.4±0.8cm,p=0.46)。在基于患者的基础上,CE-SSFP(n=29)与 SPECT 之间有良好的一致性(R=0.86,p<0.001;偏差:-1.3±7.8%LV,p=0.39),用于确定 AAR。T2-STIR 也与 SPECT 对 AAR 测量有良好的一致性(R=0.81,p<0.001,偏差:0.5±11.1%LV,p=0.81)。在基于患者的分析中,CE-SSFP 和 T2-STIR 对 AAR 的评估也有很强的一致性(R=0.84,p<0.001,偏差:-2.1±10.1%LV,p=0.31)。
在 3T 下,CE-SSFP 和 T2-STIR 均可高度准确地回顾性定量危险心肌。